Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Sarimelati Kencana Tbk. (PZZA) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Sarimelati Kencana Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Sarimelati Kencana Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 177.6K 24h volume), while Sarimelati Kencana Tbk. trades at Rp180 (market cap 549.98B, 275.6K 24h volume). The key difference: Sarimelati Kencana Tbk. is far larger — about 3.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Sarimelati Kencana Tbk. is more actively traded (275.6K versus 177.6K). Which is the better fit depends on your goals.

OBATPZZA
Market Cap
164.65B549.98B
Volume
177.6K275.6K
Lot
1.78K2.76K
Turnover
42M50.12M
Average Price
236.47181.87
Value
42M50.12M
Indicative Equilibrium Price
242
Indicative Equilibrium Volume
500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
PZZA
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Sarimelati Kencana Tbk.

PT Sarimelati Kencana Tbk. (the Company) was established based on Notarial Deed No. 132 dated December 16, 1987 of Lieke Lianadevi Tukgali, S.H.

Read more on PZZA